市場調査レポート
商品コード
1417546
サラセミア治療市場レポート:2030年までの動向、予測、競合分析Thalassemia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
サラセミア治療市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
|
サラセミア治療の動向と予測
世界のサラセミア治療市場は、2024年から2030年までのCAGRが5.1%で、2030年までに推定122億米ドルに達すると予想されます。この市場の主な促進要因は、サラセミアの有病率の増加、開発中のサラセミア治療薬の数の増加、および医薬品の研究開発とヘルスケアにかかるコストの増加です。世界のサラセミア治療市場の将来は、病院・診療所および診断研究所市場における機会によって有望視されています。
サラセミア治療市場の洞察
Lucintel社は、綿密な血液スクリーニングによるリスクの低さから、予測期間中、輸血が最も高い成長を遂げると予測しています。
北米は、サラセミアに対する意識の高まりと遺伝子治療を奨励する政府の試みにより、予測期間中最大の地域であり続けるでしょう。
Q1.市場規模は?
A1.世界のサラセミア治療市場は、2030年までに推定122億米ドルに達すると予想されています。
Q2.市場の成長予測は?
A2.世界のサラセミア治療市場は、2024年から2030年にかけてCAGR 5.1%で成長する見込みです。
Q3.市場の成長に影響を与える主な促進要因は?
A3.この市場の主な促進要因は、サラセミアの有病率の増加、開発中のサラセミア治療薬の数の増加、および医薬品の研究開発とヘルスケアにかかるコストの増加です。
Q4.市場の主要セグメントは?
A4.世界のサラセミア治療市場の将来は、病院・診療所および診断研究所市場における機会により有望と思われます。
Q5.市場の主要企業は?
A5.主要なサラセミア治療企業は以下の通りです。
Q6.今後、最大となる市場セグメントは?
A6.Lucintel社は、綿密な血液スクリーニングによるリスクの低さから、輸血が予測期間中に最も高い成長を遂げると予測しています。
Q7.市場において、今後5年間に最大になると予想される地域は?
A7.北米は、サラセミアに対する意識の高まりと遺伝子治療を奨励する政府の試みにより、予測期間中最大の地域であり続ける。
Q8.レポートのカスタマイズは可能?
A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。
Thalassemia Treatment Trends and Forecast
The future of the global thalassemia treatment market looks promising with opportunities in the hospital and clinic and diagnostic laboratory markets. The global thalassemia treatment market is expected to reach an estimated $12.2 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are the increased prevalence of thalassemia, growing number of thalassemia medications under development, as well as, growing costs for pharmaceutical research and development as well as for healthcare.
A more than 150-page report is developed to help in your business decisions.
Thalassemia Treatment by Segment
The study includes a forecast for the global thalassemia treatment by type, treatment, end use, and region.
List of Thalassemia Treatment Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thalassemia treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thalassemia treatment companies profiled in this report include-
Thalassemia Treatment Market Insights
Lucintel forecasts that blood transfusions is expected to witness the highest growth over the forecast period due to the low risk resulting from meticulous blood screening.
North America will remain the largest region over the forecast period due to growing thalassemia awareness and government attempts to encourage gene treatment.
Features of the Global Thalassemia Treatment Market
Market Size Estimates: Thalassemia treatment market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Thalassemia treatment market size by type, treatment, end use, and region in terms of value ($B).
Regional Analysis: Thalassemia treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, treatment, end use, and regions for the thalassemia treatment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thalassemia treatment market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the thalassemia treatment market size?
Answer: The global thalassemia treatment market is expected to reach an estimated $12.2 billion by 2030.
Q2. What is the growth forecast for thalassemia treatment market?
Answer: The global thalassemia treatment market is expected to grow with a CAGR of 5.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the thalassemia treatment market?
Answer: The major drivers for this market are the increased prevalence of thalassemia, growing number of thalassemia medications under development, as well as, growing costs for pharmaceutical research and development as well as for healthcare.
Q4. What are the major segments for thalassemia treatment market?
Answer: The future of the global thalassemia treatment market looks promising with opportunities in the hospital and clinic and diagnostic laboratory markets.
Q5. Who are the key thalassemia treatment market companies?
Answer: Some of the key thalassemia treatment companies are as follows.
Q6. Which thalassemia treatment market segment will be the largest in future?
Answer: Lucintel forecasts that blood transfusions is expected to witness the highest growth over the forecast period due to the low risk resulting from meticulous blood screening.
Q7. In thalassemia treatment market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to growing thalassemia awareness and government attempts to encourage gene treatment.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.